Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

2019 ◽  
Author(s):  
Keyword(s):  
Treatment Outcomes ◽  
Resource Use ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Review Study

Treatment patterns, health care resource use and outcomes in metastatic triple-negative breast cancer in Germany: retrospective chart review study (OBTAIN)

2019 ◽  
Vol 35 (8) ◽  
pp. 1405-1414 ◽  
Author(s):  
Jörg Schilling ◽  
Steffi Busch ◽  
Georg Heinrich ◽  
Karin Heinig ◽  
Christian Martin Kurbacher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Health Care ◽  
Triple Negative Breast Cancer ◽  
Resource Use ◽  
Chart Review ◽  
Triple Negative ◽  
Retrospective Chart Review ◽  
Treatment Patterns ◽  
Health Care Resource ◽  
Review Study

Improving patient safety in Palestinian hospitals: a cross-sectional and retrospective chart review study

The Lancet ◽  
2018 ◽  
Vol 391 ◽  
pp. S44
Author(s):  
Shahenaz Najjar ◽  
Nashat Nafouri ◽  
Kris Vanhaecht ◽  
Martin Euwema
Keyword(s):  
Patient Safety ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Cross Sectional ◽  
Review Study

scholarly journals Tuberous sclerosis complex: Clinical spectrum and epilepsy: A retrospective chart review study

2018 ◽  
Vol 9 (1) ◽  
pp. 154-160
Author(s):  
Sulaiman Almobarak ◽  
Mohammad Almuhaizea ◽  
Musaad Abukhaled ◽  
Suad Alyamani ◽  
Omar Dabbagh ◽  
...  
Keyword(s):  
Tuberous Sclerosis ◽  
Gene Mutation ◽  
Tuberous Sclerosis Complex ◽  
Chart Review ◽  
Clinical Presentation ◽  
Retrospective Chart Review ◽  
Neurocutaneous Disorder ◽  
Development Delay ◽  
Review Study ◽  
New Onset

Abstract Tuberous sclerosis complex (TSC) is an autosomal dominant genetic neurocutaneous disorder, with heterogeneous manifestations. We aimed to review the clinical presentation of TSC and its association with epilepsy among Saudi population. This was a retrospective chart review study of 88 patients diagnosed with TSC with or without epilepsy. In 38.6% of patients, symptoms began before 1 year of age. The most frequent initial manifestations of TSC were new onset of seizures (68.2%), skin manifestations (46.6%) and development delay (23.9%). During the evolution of the disease 65.9% had epilepsy, 17% facial angiofibromas, 13.6% Shagreen patch, 18.2% heart rhabdomyomas and 12.5% retinal hamartomas. The genetic study for TSC diagnosis was done for 44 patients, 42 (95,4%) of them were genetically confirmed, for whom 13 patients had TSC1 mutation (29.5%), 29 patients were carrying TSC2 gene mutation (65.9%), Genetic test for TSC 1 and TSC 2 were negative for 2 patients (4.5%) despite positive gene mutation in their relative with TSC. The most common manifestations were central nervous system (predominantly epilepsy) and dermatological manifestations. Most of the patients develop epilepsy with multiple seizure types. TSC 2 mutation is more common than TSC 1 mutation.

scholarly journals Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real‐World Settings: A Multicenter Retrospective Chart Review Study

2019 ◽  
Vol 24 (8) ◽  
pp. 1066-1075
Author(s):  
Arvind Dasari ◽  
Emily K. Bergsland ◽  
Al B. Benson ◽  
Beilei Cai ◽  
Lynn Huynh ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Neuroendocrine Tumors ◽  
Real World ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Treatment Patterns ◽  
Review Study

scholarly journals The Overall Response Rate Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes: A Retrospective Chart Review Study From Greece

2014 ◽  
Vol 17 (3) ◽  
pp. A223-A224
Author(s):  
V Pappa ◽  
V Fragoulakis ◽  
N Maniadakis ◽  
E Briasoulis ◽  
K Tsionos ◽  
...  
Keyword(s):  
High Risk ◽  
Myelodysplastic Syndromes ◽  
Chart Review ◽  
Overall Response Rate ◽  
Response Rate ◽  
Retrospective Chart Review ◽  
Overall Response ◽  
Review Study
Sign in / Sign up

Export Citation Format

Share Document